Appointed
Peter Tassiopoulos
Chief Executive Officer
AIFC ·
AI Financial Corp
appointed Peter Tassiopoulos to serve as our Chief Executive Officer, effective September 16, 2024
Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 4151–4200 of 18629
appointed Peter Tassiopoulos to serve as our Chief Executive Officer, effective September 16, 2024
In Ms. Strong’s absence, Richard Dziadzio, the Company’s Executive Vice President, Interim Chief Financial Officer, will assume Ms. Strong’s duties as the Company’s principal accounting officer and serve as the Company’s Executive Vice President, Interim Chief Financial Officer and Interim Chief Accounting Officer.
The Board of the Company appointed Wang Wen Lung (age 59) as the Chief Executive Officer, Chief Financial Officer, effective on August 28, 2024.
The Board of the Company appointed Wang Wen Lung (age 59) as the Chief Executive Officer, Chief Financial Officer, effective on August 28, 2024.
effective August 28, 2024, Zhenlong Zhao was appointed as Chief Executive Officer, Chief Financial Officer, Secretary and sole Director.
On August 29, 2024, Tyson Foods, Inc. (the “Company”) appointed Curt Calaway as the Company’s Chief Financial Officer.
On August 28, 2024, the Company appointed Ryan D. Lake as the Company’s Chief Financial Officer and Secretary, effective September 3, 2024
Mr. Morberg's separation will be treated as a termination by the Company without Cause subsequent to a Change in Control under that certain Executive Employment Agreement (the "Morberg Employment Agreement"), dated January 19, 2021, between the Company and Mr. Morberg
On August 23, 2024, the Board of Directors (the “Board”) of Universal Corporation (the “Company”) named Preston D. Wigner, Senior Vice President, as Chairman of the Board (“Chairman”), President and Chief Executive Officer of the Company, effective October 1, 2024.
George C. Freeman, III, who notified the Board of his retirement as Chairman, President and Chief Executive Officer and as a member of the Board on August 23, 2024, with such retirement effective October 1, 2024.
Mr. Brian Di Donato notified Immunocore Holdings plc (the “Company”) of his decision to resign as Executive Vice President, Chief Financial Officer and Head of Strategy and principal financial officer of the Company, effective December 31, 2024, to pursue another opportunity.
On August 26, 2024, Michael Mason notified Karyopharm Therapeutics Inc. (the “Company”) of his intention to resign as the Company’s Executive Vice President, Chief Financial Officer and Treasurer to pursue other professional interests.
James Langrock has been appointed Chief Financial Officer of the Company.
William E. Shea will retire from his position as Senior Vice President, Treasurer and Chief Financial Officer.
On August 27, 2024 the Board of Directors of Selectis Health, Inc., a Utah corporation (the “Company”) approved the appointment of James Creamer to the position of Chief Financial Officer, effective August 15, 2024.
On August 29, 2024, the Board of Directors (the “Board”) of P3 Health Partners Inc. (the “Company”) appointed Leif Pedersen as Chief Financial Officer of the Company, effective as of October 1, 2024 (the “Effective Date”).
Mr. Pedersen will succeed Atul Kavthekar, who resigned from his position as Chief Financial Officer of the Company effective as of the Effective Date.
Jill Robinson, age 54, has been appointed Executive Vice President, Chief Financial Officer and Treasurer of the Company.
Terence F. McGuirk, age 73, has been appointed to the role of President and Chief Executive Officer of the Company.
On August 22, 2024, Michael J. Berry informed the Company of his decision to transition from his role of Executive Vice President and Chief Financial Officer by May 23, 2025.
Ms. Kowalchik will replace David Rawden, who has served as Interim Chief Financial Officer since July 12, 2024.
On August 28, 2024, Methode Electronics, Inc. (the “Company”) announced the appointment of Laura Kowalchik as the Company’s Chief Financial Officer, effective October 1, 2024.
Chipotle’s Board of Directors appointed Scott Boatwright as Interim Chief Executive Officer
advanced the date of Mr. Rymer’s appointment as Chief Financial Officer
the Company issued a press release announcing Mr. Cook’s resignation.
On August 28, 2024, the Company announced that Amy Weaver will step down from her role as President and Chief Financial Officer of the Company effective upon the appointment of her successor or upon the filing of the Company’s annual report on Form 10-K for the fiscal year ending January 31, 2025 (the “10-K Filing Date”), if earlier.
On August 28, 2024 (the “Effective Date”), BJ’s Restaurants, Inc. (the “Company”) announced that its Board of Directors (the “Board”) approved the appointment of C. Bradford Richmond as Interim Chief Executive Officer of the Company.
On August 28, 2024, the Company announced that effective as of August 28, 2024, Gregory S. Levin would no longer serve as the Company’s Chief Executive Officer and President or as a member of the Board.
On August 23, 2024, Garrett L. Chase agreed to join Viasat, Inc. (“Viasat”) in the role of Senior Vice President and Chief Financial Officer, effective September 16, 2024.
On August 21, 2024, the board of directors (the “Board”) of IR-Med, Inc. (the “Company”) appointed Mr. Ran Ziskind to serve as its Chief Executive Officer (CEO), replacing Mr. Ronnie Klein, who had been serving as Interim CEO, effective September 1, 2024.
John Hartmann no longer serves as Chief Executive Officer of the Company.
the Board appointed Samuel Brill as Chief Executive Officer of the Company and removed him as Lead Independent Director of the Board, while maintaining his appointment as director of the Company, effective immediately.
Marvin S. Hausman, M.D. resigned as Chief Executive Officer, effective immediately.
the Board appointed a new Chief Executive Officer, Jose Antonio Reyes, effective immediately.
Jared Demark, having provided notice of his resignation, shall cease serving as chief executive officer (principal executive officer) of CoinShares Co. (the “Sponsor”).
Jean-Marie Mognetti will serve as principal executive officer of the Sponsor.
appointed William D. Schwartz as the Chief Executive Officer (CEO) of the Company, effective December 29, 2024
On August 25, 2024, the Board of Directors (the “Board”) of Endo, Inc. (the “Company”) determined that Blaise Coleman will no longer serve as the Company’s President and Chief Executive Officer, effective August 29, 2024.
The Board has appointed Scott Hirsch, currently a Board member, to serve as the Company’s Interim Chief Executive Officer (“Interim CEO”), effective August 29, 2024.
On August 26, 2024, Douglas S. Sharp notified Insperity, Inc. (“Insperity”) of his decision to retire from Insperity, effective November 15, 2024.
James D. Allison, age 55, will assume the role of Executive Vice President of Finance, Chief Financial Officer and Treasurer, effective as of Mr. Sharp’s retirement.
Effective as of August 16, 2024, Harry Green no longer serves as the Chief Financial Officer of African Agriculture Holdings, Inc. (the “Company”).
The resignations of Kristi Jones, the Company’s Chief Executive Officer, Mathias Oelke, the Company’s Chief Scientific Officer, and Albert N. Marchio II, the Company’s Interim Chief Financial Officer and its principal financial and accounting officer from the Company were not due to any disagreements with the Company on any matters relating to the Company’s operations, policies or practices.
The resignations of Kristi Jones, the Company’s Chief Executive Officer, Mathias Oelke, the Company’s Chief Scientific Officer, and Albert N. Marchio II, the Company’s Interim Chief Financial Officer and its principal financial and accounting officer from the Company were not due to any disagreements with the Company on any matters relating to the Company’s operations, policies or practices.
On August 26, 2024, the Board of Directors of the Company (the “Board”) appointed Brett Kaplan, the Company’s Chief Operating Officer, to serve as principal financial officer.
On August 21, 2024, Mr. Don Kalkofen tendered his resignation as Chief Financial Officer of Alpha Cognition Inc. (the “Company”), effective October 1, 2024.
On August 20, 2024, Tenon Medical, Inc. (the “Company”) entered into an offer letter (the “Letter”) with Kevin Williamson pursuant to which Mr. Williamson was appointed as Chief Financial Officer of the Company, effective as of September 3, 2024.
On August 21, 2024, Ayro, Inc. (the “Company”) appointed Joseph Ramelli to the position of Chief Financial Officer of the Company, effective as August 21, 2024.
On August 26, 2024, Brian Mitts resigned from his positions as Chief Executive Officer, Chief Financial Officer, Assistant Secretary and Treasurer of the Company and its subsidiaries. Mr. Mitts will continue to serve as the Company’s President and a member of the Board of Directors of the Company (the “Board”).
the Board also appointed Paul Richards as the Company’s Chief Financial Officer, Assistant Secretary and Treasurer.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.